17.3 C
New York
Friday, June 9, 2023

Insights Into Geron Corporation (GERN) Exposure By Institutions

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. After-hours trades for Geron Corporation (GERN) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.01, or 0.32%, to $3.14. The Geron Corporation has recorded 60,902 volume in the after hours trading session. Most recently, Yahoo Finance reported about the stock as it publicized that Geron Oral Presentation at Upcoming ASCO Annual Meeting to Highlight Meaningful Continuous Transfusion Independence Observed in Imetelstat-Treated Lower Risk MDS Patients in IMerge Phase 3.

<25-cent Stock Takes $11T Commodities Sector Digital

One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.

All the details are in the FREE online report you can get here.


Stocks Info

Geron Corporation is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $3.13 and fluctuated between $3.1700 as its day high and $3.0500 as its day low. The current market capitalization of Geron Corporation is $1.54B. A total of 4.7 million shares were traded on the day, compared to an average of 5.69M shares.

Insider Activity

Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, GERN has seen 3 BUY and 1 SELL insider trades, representing the acquisition of 44,360 and the disposition of 35,000 shares. Over the last 12 months, there were 16 BUYs and 7 SELLs from insiders. Insiders purchased 2,233,840 shares during that period but sold 2,159,719.

In the most recent transaction, LAWLIS V BRYAN sold 35,000 shares of GERN for 3.00 per share on May 11. After the transaction, the Director now owns 0 company shares. In a previous transaction on May 01, Molineaux Susan sold 35,000 shares at 2.48 per share. GERN shares that Director owns now total 0.

Among the insiders who sold shares, SCARLETT JOHN A disposed of 446,668 shares on Feb 10 at a per-share price of $3.00. This resulted in the Chairman, President and CEO holding 0 shares of GERN after the transaction. In another insider transaction, SCARLETT JOHN A sold 446,666 shares at $3.03 per share on Feb 09. Company shares held by the Chairman, President and CEO now total 0.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for GERN in the last 3 months, the mean price target is $4.83 with high estimates of $6.00 and low estimates of $4.00. In terms of 52-week highs and lows, GERN has a high of $3.84 and a low of $1.18.

As of this writing, GERN has an earnings estimate of -$0.08 per share for the current quarter. EPS was calculated based on a consensus of 6 estimates, with a high estimate of -$0.07 per share and a lower estimate of -$0.11. The company reported an EPS of -$0.1 in the last quarter, which was 16.70% higher than expectations of -$0.12.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. GERN’s latest balance sheet shows that the firm has $183.72M in Cash & Short Term Investments as of fiscal 2021. There were $55.00M in debt and $45.52M in liabilities at the time. Its Book Value Per Share was $0.60, while its Total Shareholder’s Equity was $126.42M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for GERN is Buy with a score of 4.40.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles